Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs?

Infection Control and Hospital Epidemiology

Volumn 20, Issue 6, 1999, Pages 408-411

  Abramson, Murray A ^a,b   Sexton, Daniel J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ADULT; AGED; ARTICLE; BACTEREMIA; COMPARATIVE STUDY; CROSS INFECTION; DRUG EFFECT; ECONOMICS; HOSPITAL COST; HUMAN; LENGTH OF STAY; MIDDLE AGED; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CROSS INFECTION; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; METHICILLIN; METHICILLIN RESISTANCE; MIDDLE AGED; NORTH CAROLINA; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0033141353     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/501641     Document Type: Article

References (11)

1. Banerjee S, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-89S.
2. Panlilio AL, Culver DH, Gaynes RP, Banerjee S, Henderson TS, Tolson JS, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992;13:582-586.
3. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601.
4. Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control 1981;2:110-116.
5. Wakefield DS, Helms CM, Massanari RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-192.
6. Rose RR, Hunting KJ, Townsend TR, Wenzel RP. Morbidity/mortality and economics of hospital-acquired bloodstream infections: a controlled study. South Med J 1977;70:1267-1269.
7. Spengler RF, Greenough WB. Hospital costs and mortality attributed to nosocomial bacteremias. JAMA 1978;240:2455-2458.
8. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16: 128-140.
9. Hindler JA, Warner NL. Effect of source of Mueller-Hinton agar on detection of oxacillin resistance in Staphylococcus aureus using a screening methodology. J Clin Microbiol 1997;25:734-735.
10. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-2645.
11. International Classification of Diseases. 9th Revision, Clinical Modification: ICD-9-CM. 3rd ed. USDHHS publication no. (PHS) 89-1260. Washington, DC: US Department of Health and Human Services; 1989.